Phase 2 Study of Daratumumab - Assess good, partial, or better response after 4 cycles - 101931

Spotlight
Video

Phase 2 Study of Daratumumab - Assess good, partial, or better response after 4 cycles

ASHReport has 256 videos Subscribe Here

Loading........
Description: Habte Yimer, MD from Texas Oncology discusses Phase 2 study of Daratumumab and assess good, partial, or better response after 4 cycles at the 2017 American Society of Hematology.
Shared By : ASHReport
Posted on : 01/12/18
Added : 5 months ago
Category : Multiple Myeloma